Literature DB >> 11441823

Influenza virus-induced AP-1-dependent gene expression requires activation of the JNK signaling pathway.

S Ludwig1, C Ehrhardt, E R Neumeier, M Kracht, U R Rapp, S Pleschka.   

Abstract

Influenza A virus infection of cells results in the induction of a variety of antiviral cytokines, including those that are regulated by transcription factors of the activating protein-1 (AP-1) family. Here we show that influenza virus infection induces AP-1-dependent gene expression in productively infected cells but not in cells that do not support viral replication. Among the AP-1 factors identified to bind to their cognate DNA element during viral infections of Madin-Darby canine kidney and U937 cells are those that are regulated via phosphorylation by JNKs. Accordingly, we observed that induction of AP-1-dependent gene expression correlates with a strong activation of JNK in permissive cells, which appears to be caused by viral RNA accumulation during replication. Blockade of JNK signaling at several levels of the cascade by transient expression of dominant negative kinase mutants and inhibitory proteins resulted in inhibition of virus-induced JNK activation, reduced AP-1 activity, and impaired transactivation of the IFN-beta promoter. Virus yields from transfected and infected cells in which JNK signaling was inhibited were higher compared with the levels from control cells. Therefore, we conclude that virus-induced activation of JNK and AP-1 is part of the innate antiviral response of the cell.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11441823

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  Mixed Lineage Kinase 3 deficiency delays viral clearance in the lung and is associated with diminished influenza-induced cytopathic effect in infected cells.

Authors:  Emily A Desmet; Joseph A Hollenbaugh; Patricia J Sime; Terry W Wright; David J Topham; Andrea J Sant; Toru Takimoto; Stephen Dewhurst; Sanjay B Maggirwar
Journal:  Virology       Date:  2010-02-25       Impact factor: 3.616

2.  Reovirus infection activates JNK and the JNK-dependent transcription factor c-Jun.

Authors:  P Clarke; S M Meintzer; C Widmann; G L Johnson; K L Tyler
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

3.  ERK- and JNK-dependent signaling pathways contribute to Bombyx mori nucleopolyhedrovirus infection.

Authors:  Susumu Katsuma; Kazuei Mita; Toru Shimada
Journal:  J Virol       Date:  2007-10-03       Impact factor: 5.103

4.  Innate immune response to H3N2 and H1N1 influenza virus infection in a human lung organ culture model.

Authors:  Wenxin Wu; J Leland Booth; Elizabeth S Duggan; Shuhua Wu; Krupa B Patel; K Mark Coggeshall; Jordan P Metcalf
Journal:  Virology       Date:  2009-11-12       Impact factor: 3.616

Review 5.  Current and future developments in the treatment of virus-induced hypercytokinemia.

Authors:  Jonathan P Wong; Satya Viswanathan; Ming Wang; Lun-Quan Sun; Graeme C Clark; Riccardo V D'Elia
Journal:  Future Med Chem       Date:  2017-01-27       Impact factor: 3.808

6.  A comprehensive map of the influenza A virus replication cycle.

Authors:  Yukiko Matsuoka; Hiromi Matsumae; Manami Katoh; Amie J Eisfeld; Gabriele Neumann; Takeshi Hase; Samik Ghosh; Jason E Shoemaker; Tiago J S Lopes; Tokiko Watanabe; Shinji Watanabe; Satoshi Fukuyama; Hiroaki Kitano; Yoshihiro Kawaoka
Journal:  BMC Syst Biol       Date:  2013-10-02

Review 7.  Role of MAPK/MNK1 signaling in virus replication.

Authors:  Ram Kumar; Nitin Khandelwal; Riyesh Thachamvally; Bhupendra Nath Tripathi; Sanjay Barua; Sudhir Kumar Kashyap; Sunil Maherchandani; Naveen Kumar
Journal:  Virus Res       Date:  2018-06-01       Impact factor: 3.303

8.  The effects of the Xijiao Dihuang decoction combined with Yinqiao powder on miRNA-mRNA profiles in mice infected with influenza a virus.

Authors:  Ke Li; Xiaoming Chen; Jing Zhong; Hehe Ye; Shujing Zhang; Dongyu Ge; Xudan Wang; Ying Wu
Journal:  BMC Complement Med Ther       Date:  2020-09-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.